These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Lipid profile improvement following celiprolol. Herrmann JM; von Heyman F; Freischütz G J Int Med Res; 1988; 16 Suppl 1():39A-46A. PubMed ID: 2906016 [TBL] [Abstract][Full Text] [Related]
7. Effects of bisoprolol on blood pressure, serum lipids and HDL-cholesterol in essential hypertension. Frithz G; Weiner L Eur J Clin Pharmacol; 1987; 32(1):77-80. PubMed ID: 2884116 [TBL] [Abstract][Full Text] [Related]
8. [Serum lipids of alcoholics before and following abstinence. Significance for coronary risk]. Clemens MR; Schied HW; Waller HD J Clin Chem Clin Biochem; 1986 Jun; 24(6):369-74. PubMed ID: 3746201 [TBL] [Abstract][Full Text] [Related]
9. Effects of arotinolol on serum lipid and apolipoprotein levels in patients with mild essential hypertension. Sasaki J; Handa K; Arakawa K Clin Ther; 1989; 11(5):580-3. PubMed ID: 2478285 [TBL] [Abstract][Full Text] [Related]
10. The effects of beta-adrenergic blocking agents on blood lipid levels. Wolinsky H Clin Cardiol; 1987 Oct; 10(10):561-6. PubMed ID: 2889552 [TBL] [Abstract][Full Text] [Related]
11. Effect of sotalol withdrawal on serum lipids and lipoprotein lipase activity. Lehtonen A; Hietanen E; Marniemi J; Peltonen P; Nikkilä EA Int J Clin Pharmacol Ther Toxicol; 1983 Feb; 21(2):73-6. PubMed ID: 6840928 [TBL] [Abstract][Full Text] [Related]
12. Effects of carvedilol on serum lipids in patients with essential hypertension. Goto Y; Tamachi H; Fusegawa Y; Nakaya N; Homma Y; Mikami M; Iori S; Yamazaki A J Cardiovasc Pharmacol; 1991; 18 Suppl 4():S45-50. PubMed ID: 1721979 [TBL] [Abstract][Full Text] [Related]
13. Moderate alcohol intake and lower risk of coronary heart disease: meta-analysis of effects on lipids and haemostatic factors. Rimm EB; Williams P; Fosher K; Criqui M; Stampfer MJ BMJ; 1999 Dec; 319(7224):1523-8. PubMed ID: 10591709 [TBL] [Abstract][Full Text] [Related]
14. Lipid effects of celiprolol, a new cardioselective beta-blocker, versus propranolol. Sirtori CR; Johnson B; Vaccarino V; Montanari G; Cremoncini M; Gianfranceschi G; Sirtori M; Dujovne CA Clin Pharmacol Ther; 1989 Jun; 45(6):617-26. PubMed ID: 2567218 [TBL] [Abstract][Full Text] [Related]
15. Effects of alpha- and beta-blocker antihypertensive therapy on blood lipids: a multicenter trial. Goto Y Am J Med; 1984 Feb; 76(2A):72-8. PubMed ID: 6142645 [TBL] [Abstract][Full Text] [Related]
17. Beta-blockade and plasma lipids. Lehtonen A J Pharmacol; 1983; 14 Suppl 2():203-8. PubMed ID: 6138468 [TBL] [Abstract][Full Text] [Related]
18. [Effect of celiprolol and metoprolol on serum lipids in patients with various forms of hyperlipoproteinemia]. Pristautz H; Stradner F Wien Med Wochenschr; 1986 Sep; 136(17):443-8. PubMed ID: 2879389 [TBL] [Abstract][Full Text] [Related]
19. Comparison of talinolol and atenolol effects on blood pressure in relation to lipid and glucose metabolic parameters. Results from the TALIP study. Sourgens H; Schmidt J; Derendorf H Int J Clin Pharmacol Ther; 2003 Jan; 41(1):22-9. PubMed ID: 12564742 [TBL] [Abstract][Full Text] [Related]
20. A comparison of the hypotensive and metabolic effects of 50 and 100 mg atenolol per day. Lithell H; Aberg H; Selinus I Drugs Exp Clin Res; 1986; 12(5):393-6. PubMed ID: 3720523 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]